Discover 1,593 paid clinical trials in Washington State. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Washington State offers a wide range of paid volunteering opportunities for both healthy participants and those looking for condition-specific clinical studies. Key centers in Seattle, Spokane, and Tacoma are actively recruiting participants, providing access to advanced medical treatments and innovative care solutions.
Filter
1
Filter results
Results: 1,593
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
for
Geographic Atrophy (GA),
Location: Waterford CT, Springfield MA, Westbury NY, Oceanside NY,
Sponsor: ONL Therapeutics
Sex: All
Age: 55+
Code: NCT06659445
Phase2, Recruiting
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
for
Alzheimer's Disease
Location: Methuen MA, Willow Grove PA, Ottawa, Atlantis FL,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 50 - 70+
Code: NCT07094516
Phase2, Recruiting
A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)
for
Chronic Graft Versus Host Disease
Location: Boston MA, New York NY, Washington D.C. DC, Toronto,
Sponsor: Sanofi
Sex: All
Age: 1 - 18
Code: NCT07116031
Phase2, Recruiting
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
for
Major Depressive Disorder (MDD)
Location: Watertown MA, New York NY, Marlton NJ, Media PA,
Sponsor: Draig Therapeutics Ltd
Sex: All
Age: 18 - 70+
Code: NCT07300969
Phase2, Recruiting
Phase 2 EL219 Versus Liposomal Amphotericin B or Voriconazole for Early Antifungal Therapy
for
Invasive Mould Infection
Location: Boston MA, Baltimore MD, Toronto, Hamilton, Augusta GA,
Sponsor: Elion Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07215273
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)
for
ADHD, ADHD - Attention Deficit Disorder With Hyperactivity
Location: Seattle WA
Sponsor: Seattle Children's Hospital
Sex: All
Age: 13 - 17
Code: NCT07281092
Recruiting
A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia
for
Autoimmune Haemolytic Anaemia
Location: Boston MA, Providence RI, New Haven CT, The Bronx NY,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT07086976
Phase3, Recruiting
Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Study
for
CADASIL
Location: Providence RI, New York NY, Atlanta GA, Chicago IL,
Sponsor: University of Wisconsin, Madison
Sex: All
Age: 18+
Code: NCT05677880
Recruiting
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
A Study of TSRA-196 in Adults With PiZZ Alpha-1 Antitrypsin Deficiency (AATD)
for
Alpha-1 Antitrypsin Deficiency (AATD)
Location: Boston MA, Charleston SC, Jacksonville FL, Rochester MN,
Sponsor: Tessera Therapeutics, Inc.
Sex: All
Age: 18 - 70
Code: NCT07227207
Phase1, Phase2, Recruiting
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
for
Locally Advanced or Metastatic Solid Tumors, Colorectal Cancer,
Location: Fairfax VA, Denver CO, Sarasota FL, Nashville TN,
Sponsor: ArriVent BioPharma, Inc.
Sex: All
Age: 18+
Code: NCT07066657
Phase1, Recruiting
Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica
for
Polymyalgia Rheumatica
Location: Sherbrooke, Trois-Rivieres, Willow Grove PA,
Sponsor: Sanofi
Sex: All
Age: 50+
Code: NCT07286214
Recruiting
A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation
for
Kidney Transplant Rejection
Location: Boston MA, The Bronx NY, New York NY, Baltimore MD,
Sponsor: Sanofi
Sex: All
Age: 18 - 70
Code: NCT07412470
Phase2, Phase3, Recruiting
A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
for
Chronic Myelogenous Leukemia - Chronic Phase
Location: East Setauket NY, Stamford CT, Baltimore MD,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07091019
Recruiting
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
for
Respiratory Syncytial Virus Immunization,
Location: Boston MA, Brookline MA, Methuen MA, East Greenwich RI,
Sponsor: Sanofi
Sex: All
Age: 60+
Code: NCT07734649
Phase1, Phase2, Recruiting
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
for
Advanced Solid Tumor, Diffuse Large B Cell Lymphoma,
Location: Boston MA, Philadelphia PA, Charlottesville VA,